Tag Archives: Takeda
Featured Stories
FDA Advisors Set to Examine Metal-on-Metal Hip Implant Safety Concerns
Thousands of people with metal-on-metal hip implant devices could soon get some answers from the U.S. Food & Drug Administration (FDA) about the dangers they face. Tomorrow, the agency will convene a panel of outside medical experts to examine the safety record of metal-on-metal hip replacements, and recommend the ...
Smith & Nephew Says Metal-on-Metal Hip Replacement Controversy Slowing Sales of Birmingham Hip Resurfacing System
Medical device maker Smith & Nephew has reported a drop in sales of its metal-on-metal hip implant devices. According to the company, hip implant sales were down 2 percent during the first quarter of 2012, largely because its Birmingham Hip Resurfacing System suffered from an association with other metal-on-metal hip ...
Knee Replacement Patients Should Consider Nickel Allergies before Surgery
Individuals considering undergoing knee replacement surgery should ask their doctors to run a test to determine if they have a nickel allergy. Determining if a patient suffers from a nickel allergy will ensure the right knee implant is chosen for their surgery, and possibly save them from considerable pain and ...
National Law Firms Calls for More FDA Action on Actos Bladder Cancer Threat
A national law firm is not satisfied with the way the U.S. Food & Drug Administration (FDA) has handled warnings regarding Actos (pioglitazone) bladder cancer risks. In a statement published today, Parker Waichman LLP called on the FDA to compel Takeda Pharmaceuticals, the maker of the type 2 diabetes drug, ...
Zadroga Act Cancer Decision Expected This Week
The federal official tasked with determining what ailments should be covered by the federal Zadroga Act is expected to decide by Saturday if certain cancers will be eligible for compensation. The decision is being eagerly awaited by thousands of first responders who believe they developed cancer due to exposure ...
Smith & Nephew Recalls Metal-on-Metal Hip Implant Component
Medical device maker, Smith & Nephew, just issued a recall for a metal-on-metal hip implant component, a part of one of its all-metal hip replacement systems.
Bayer Yaz, Yasmin Blood Clot Lawsuit Settlements Stand at $147 Million
Bayer AG reported yesterday that it continues to settle Yaz and Yasmin birth control pill lawsuits. According to a report from Bloomberg News, the company said in its latest Stockholder Newsletter that it has settled 651 Yaz and Yasmin blood clot lawsuits for a total of $147 million. The average ...
Metal-on-Metal Hip Implant Lawyer Takes Issue with Statements Made by DePuy Orthpaedics Official During FDA Meeting
An attorney with a national law firm that represents victims of alleged metal-on-metal hip implant injuries has expressed dismay at some statements made last week regarding the regulation of all-metal hip replacement devices by an official with DePuy Orthopaedics. According to Daniel Burke, Senior Litigation Counsel at Parker ...
Fracking Releasing Hazardous Chemicals into Local Waterways
Study shows two hazardous chemicals—ammonium & iodide—are being released & spilled into Pennsylvania and W.Virginia waterways from fracking operations in Marcellus shale.
Actos Bladder Cancer Lawsuit Filed by West Virginia Resident
Actos (pioglitazone) continues to be named in lawsuits alleging long-term use of the type 2 diabetes drug caused patients to develop bladder cancer. Just last week, the national law firm of Parker Waichman LLP filed suit against Takeda Pharmaceuticals on behalf of a West Virginia man who developed bladder cancer ...Actos Makers Continue to Face Bladder Cancer Claims
Lawsuits continue to be filed over Actos, a type 2 diabetes drug developed by Takeda and Eli Lilly. Plaintiffs in the litigation allege that Actos contributed to bladder cancer. Drug makers are accused of failing to disclose this risk to … Continue reading
$2.4 Billion Settlement Announced in Actos Bladder Cancer Cases
On Tuesday, Takeda Pharmaceuticals announced a settlement that could go as high as $2.7 billion to resolve thousands of lawsuits from patients and their families who claim the diabetes drug Actos (pioglitazone) caused their bladder cancer. The New York Times … Continue reading
Posted in Actos, Health Concerns, Legal News, Pharmaceuticals
Tagged Lawsuits, pharmaceuticals, Settlement, Takeda
Takeda to Potentially Settle Actos Lawsuits for $2.2B
Reportedly, Takeda Pharmaceutical Co. has offered to settle more than 8,000 Actos lawsuits alleging the diabetes drug caused cancer for $2.2 billion; each case would receive about $275,000. Bloomberg reports that it would be one of the largest settlements in … Continue reading
Posted in Defective Products, Health Concerns, Legal News, Pharmaceuticals, Product Recalls
Tagged cancer, Diabetes, drug maker, Lawsuits, Takeda
